—
Pharmaceutical Excipients Market" projects that the world pharmaceuticals excipients market would reach $6.4 billion by 2020 at a CAGR of 7.6% during 2020 and 2027.Organic chemicals would continue to be the highest revenue-generating segment during the forecast period. North America and Europe will continue to be the lead revenue generating economies through 2027. These regions collectively accounted for about three-fourth of share in the global pharmaceutical excipients market in 2020.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/1053
Factors that drive the global pharmaceutical excipients market are rising demand for pharmaceutical drugs, increasing popularity of functional excipients, drug pipeline, development of novel excipients, and increasing generic drugs market caused by expiration of various bestseller drugs patents. Factors that are likely to impede the market growth include, supply chain issues, high market fragmentation, and implementation of stringent regulations.
Binders segment generated highest revenue in 2015 and is anticipated to maintain this trend throughout the forecast period. This is attributed to the higher use of binders in pharmaceutical drugs as compared to fillers and diluents. However, fillers and diluents led this segment in terms of volume (units) in 2015 and accounted for about one fourth of the overall market. Economical cost and high popularity of fillers and diluents across pharmaceutical and excipient industries were the key factors responsible for the dominance of filler and diluents segment.
Key findings of the study:
Binders generated the highest revenue accounting for about two-seventh of the overall market revenue in 2015.
In the inorganic chemical category, halite's segment is projected to grow at the highest CAGR of 29.2% during the forecast period.
Calcium phosphate (inorganic chemical) segment is projected to reach $539.9 million by 2027 at a CAGR of 10.5%.
In the organic chemicals category, carbohydrates generated the highest revenue and is expected to dominate till 2020.
Disintegrants segment is projected to grow at a highest CAGR of 12.6% from 2020 to 2027.
Proteins segment (Petrochemicals category) generated highest revenue in 2015; however, mineral hydrocarbons segment is expected to grow at the highest CAGR of 7.0% during the period under consideration.
Asia-Pacific is anticipated to be the fastest growing pharmaceutical excipients market, for both organic and inorganic chemicals, in terms of volume and revenue during 2020 and 2027.
Top Key Players :
Ashland Inc.
BASF SE
Associated British Foods Plc
Akzo Nobel N.V.
The Dow Chemical Company
Evonik
Merck
M. Huber Corporation
Covidien Plc
Archer Daniels Midland.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/1053
Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Phone: 18007925285
Website: https://www.alliedmarketresearch.com/
Release ID: 89031478